For 30 years, other technologies have tried to match the effectiveness of Leksell Gamma Knife® in treating the brain. Despite technological advancements and the use of bells and whistles, like robotic arms and built-in imaging, the fact remains that Gamma Knife surgery is the most effective modality.

Accuracy is critical when treating the brain, and Gamma Knife surgery provides the most consistently accurate radiation delivery to ensure the highest quality of care. And when it comes to your brain, proven is better, especially when proven combines with continual research to create a fourth generation of Gamma Knife technology.

30 Reasons to Choose Gamma Knife

Leksell Gamma Knife® is the only gold standard for non-invasive treatment of brain disorders and brain metastases
Gamma Knife surgery treats critical disorders in the brain, for example, benign and malignant tumors and functional disorders
Gamma Knife surgery is a single-session treatment concluded in one day, with either no, or short, convalescence
Gamma Knife surgery is a minimally invasive procedure
Gamma Knife surgery is complementary to open brain surgery and radiation therapy
The stereotactic Leksell® Coordinate Frame ensures highest precision throughout the entire treatment procedure
Over 300,000 patients have been treated with Gamma Knife surgery
45,000 patients were treated with Gamma Knife surgery in 2004
220 Gamma Knife systems are installed worldwide, as of August 2005
There are 100 Gamma Knife systems installed in the United States
Numerous scientific studies show Gamma Knife surgery is safe, effective and has low complication rates
More than 2,000 peer-reviewed articles have been published about Gamma Knife surgery
Leksell Gamma Knife® has long term results dating back to 1968, with a 15-year published study
Leksell Gamma Knife® offers radiological accuracy of 0.3mm
The average radiological accuracy of Leksell Gamma Knife® is 0.15mm*
*Shown in 332 measurements on 189 installed Gamma Knife® systems
Gamma Knife surgery is 30-70% less costly than open surgery*
*Van Rojen et. al Acta Neurochir. (Wein) 139 (10) 1997, Rutigliano et. Al. Open Surgery, 1995;37(3)
Gamma Knife surgery is widely accepted and reimbursed by insurance companies
There are more than 2,100 members in the users group Leksell Gamma Knife® Society - sharing and developing scientific knowledge
The Journal of Neurosurgery has published three special editions featuring the proceedings of the International Leksell Gamma Knife® Society
More than 100,000 brain metastases have been treated with Gamma Knife surgery
Gamma Knife surgery of vestibular schwannomas offers a tumor control rate of more than 95% with 80% preserved hearing*
*Regis et.al functional outcome of radiosurgical cases and review of vestibular schwannomas. 1,000 successive cases and review of the literature. Neurochirurgie 2004, June.
Worldwide, the number of patients treated with arteriovenous malformations is 33,540 and more than 288 papers in scientific literature discuss this subject
There are more than 190 papers in the scientific literature discussing Gamma Knife surgery on acoustic neuroma patients
36,602 meningioma patients have been treated with Gamma Knife surgery
High throughput and efficient treatment enable patient volumes >1,000 per year
More than 99.5% uptime with Leksell Gamma Knife®
Gamma Knife® treatment rooms need less shielding than other irradiation techniques
Leksell Gamma Knife® 4C is the fourth generation of the most successful radiosurgery weapon in the fight against brain disorders
Leksell GammaPlan® 4C can use any stereotactic or non-stereotactic image study for planning
Leksell Gamma Knife® is made by Elekta, an international medical-technology group providing non-invasive or minimally invasive clinical solutions for improved cancer care and management of brain disorders

® Surgery Facts

Call 407-303-2724 or toll free 1-800-241-1089.

Leksell Gamma Knife is a registered trademark of Elekta Instruments, Inc